Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies
- PMID: 26347100
- PMCID: PMC4621029
- DOI: 10.1093/annonc/mdv355
Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies
Abstract
Background: Body mass index (BMI), a measure of obesity typically assessed in middle age or later, is known to be positively associated with pancreatic cancer. However, little evidence exists regarding the influence of central adiposity, a high BMI during early adulthood, and weight gain after early adulthood on pancreatic cancer risk.
Design: We conducted a pooled analysis of individual-level data from 20 prospective cohort studies in the National Cancer Institute BMI and Mortality Cohort Consortium to examine the association of pancreatic cancer mortality with measures of central adiposity (e.g. waist circumference; n = 647 478; 1947 pancreatic cancer deaths), BMI during early adulthood (ages 18-21 years) and BMI change between early adulthood and cohort enrollment, mostly in middle age or later (n = 1 096 492; 3223 pancreatic cancer deaths). Multivariable hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using Cox proportional hazards regression models.
Results: Higher waist-to-hip ratio (HR = 1.09, 95% CI 1.02-1.17 per 0.1 increment) and waist circumference (HR = 1.07, 95% CI 1.00-1.14 per 10 cm) were associated with increased risk of pancreatic cancer mortality, even when adjusted for BMI at baseline. BMI during early adulthood was associated with increased pancreatic cancer mortality (HR = 1.18, 95% CI 1.11-1.25 per 5 kg/m(2)), with increased risk observed in both overweight and obese individuals (compared with BMI of 21.0 to <23 kg/m(2), HR = 1.36, 95% CI 1.20-1.55 for BMI 25.0 < 27.5 kg/m(2), HR = 1.48, 95% CI 1.20-1.84 for BMI 27.5 to <30 kg/m(2), HR = 1.43, 95% CI 1.11-1.85 for BMI ≥30 kg/m(2)). BMI gain after early adulthood, adjusted for early adult BMI, was less strongly associated with pancreatic cancer mortality (HR = 1.05, 95% CI 1.01-1.10 per 5 kg/m(2)).
Conclusions: Our results support an association between pancreatic cancer mortality and central obesity, independent of BMI, and also suggest that being overweight or obese during early adulthood may be important in influencing pancreatic cancer mortality risk later in life.
Keywords: BMI; central adiposity; pancreatic cancer; pooled analysis.
© The Author 2015. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
References
-
- Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. In IARC Cancer Base No. 5. version 2.0 Edition Lyon, France: IARC Press; 2002.
-
- Cancer Facts & Figures 2011. Atlanta, GA: American Cancer Society; 2011.
-
- Lowenfels AB, Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol 2006; 20: 197–209. - PubMed
-
- Ma J, Jemal A. The rise and fall of cancer mortality in the USA: why does pancreatic cancer not follow the trend? Future Oncol 2013; 9: 917–919. - PubMed
-
- Bosetti C, Bertuccio P, Malvezzi M et al. . Cancer mortality in Europe, 2005–2009, and an overview of trends since 1980. Ann Oncol 2013; 24: 2657–2671. - PubMed
Publication types
MeSH terms
Grants and funding
- ES 000260/ES/NIEHS NIH HHS/United States
- UM1 CA182934/CA/NCI NIH HHS/United States
- U01 AG18033/AG/NIA NIH HHS/United States
- R01 CA49449/CA/NCI NIH HHS/United States
- CA047988/CA/NCI NIH HHS/United States
- R01- HL26210/HL/NHLBI NIH HHS/United States
- P01 CA87969/CA/NCI NIH HHS/United States
- UM1 CA182913/CA/NCI NIH HHS/United States
- R01 CA047988/CA/NCI NIH HHS/United States
- P01 CA055075/CA/NCI NIH HHS/United States
- R01 CA097193/CA/NCI NIH HHS/United States
- U01 AG018033/AG/NIA NIH HHS/United States
- P30 CA016087/CA/NCI NIH HHS/United States
- HL043851/HL/NHLBI NIH HHS/United States
- R01 CA39742/CA/NCI NIH HHS/United States
- Z99CA999999/CA/NCI NIH HHS/United States
- CA 97193/CA/NCI NIH HHS/United States
- R01-CA14703/CA/NCI NIH HHS/United States
- P30 CA015704/CA/NCI NIH HHS/United States
- R01 CA 098661/CA/NCI NIH HHS/United States
- R01 HL043851/HL/NHLBI NIH HHS/United States
- K05 CA154337/CA/NCI NIH HHS/United States
- HL 26490/HL/NHLBI NIH HHS/United States
- 5U01AG018033/AG/NIA NIH HHS/United States
- CA 77398/CA/NCI NIH HHS/United States
- R01 HL034595/HL/NHLBI NIH HHS/United States
- Z01 ES049030/ImNIH/Intramural NIH HHS/United States
- P30 ES000260/ES/NIEHS NIH HHS/United States
- Z01 P010119/PHS HHS/United States
- Y99 CA999999/CA/NCI NIH HHS/United States
- HL 34595/HL/NHLBI NIH HHS/United States
- R01 CA124908/CA/NCI NIH HHS/United States
- CA 40360/CA/NCI NIH HHS/United States
- R01 CA039742/CA/NCI NIH HHS/United States
- CA 34944/CA/NCI NIH HHS/United States
- R01 CA077398/CA/NCI NIH HHS/United States
- Z01 ES049030-11/ES/NIEHS NIH HHS/United States
- R01 HL080467/HL/NHLBI NIH HHS/United States
- UM1 CA167552/CA/NCI NIH HHS/United States
- HL080467/HL/NHLBI NIH HHS/United States
- R01 CA105069/CA/NCI NIH HHS/United States
- R01 CA040360/CA/NCI NIH HHS/United States
- CA105069/CA/NCI NIH HHS/United States
- UM1 CA186107/CA/NCI NIH HHS/United States
- R01 CA034944/CA/NCI NIH HHS/United States
- CA 016087/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
